Kisspeptin-10: A Tracking Guide for the Upstream Hormone Signal

Kisspeptin-10 is interesting because it sits further upstream than almost anything else self-experimenters touch. Instead of replacing a downstream hormone, it nudges the signal that asks the pituitary to release LH and FSH. That makes the tracking question different from a typical peptide.

What it does

Kisspeptin-10 is a 10-amino-acid fragment derived from the KISS1 gene product. It binds the KISS1R (formerly GPR54) receptor on hypothalamic neurons and stimulates GnRH release, which in turn drives LH and FSH from the pituitary. In clinical research it has been studied in hypogonadotropic hypogonadism, fertility evaluations, and reproductive endocrinology contexts.

It is not a testosterone replacement and it does not bypass a damaged HPG axis. If the downstream pituitary or gonadal tissue is not responsive, kisspeptin does not fix that.

Typical protocol shape

Research protocols vary widely. Some are single-dose challenge tests used diagnostically. Others involve repeated subcutaneous or intranasal administration. Self-experimentation typically uses subcutaneous injection on a daily or every-other-day pattern over a defined window. Half-life is short, which is why pulsatile or repeated dosing is common in studies.

We will not publish specific dose ranges. The clinical literature is the right reference.

What to track daily

• Injection time, dose, route, and site
• Libido on a 1 to 10 scale
• Morning erections (frequency and quality, for relevant users)
• Mood and motivation
• Sleep quality
• Any flushing, headache, or injection-site reaction

What to track weekly

• Body weight and a brief energy summary
• Training drive and recovery
• Menstrual cycle phase, if applicable, since kisspeptin tracking in cycling individuals must account for natural phase variation

Bloodwork worth doing

This is where kisspeptin tracking lives or dies. Without labs you are guessing.

• LH and FSH, baseline and on-protocol, ideally timed consistently
• Total and free testosterone (men)
• Estradiol
• Prolactin
• SHBG
• For fertility contexts: semen analysis or relevant female reproductive panels under clinical guidance

Realistic expectations

The honest expectation is that kisspeptin-10 is a research tool more than a polished therapeutic. Some users report subjective increases in libido and a measurable LH bump. Others see little change. Long-term safety data in healthy adults is limited. Treat it as an experiment with bloodwork, not a routine.

Common mistakes

• Skipping baseline labs, then having nothing to compare against
• Drawing post-dose labs at random times rather than at a consistent interval
• Running it alongside other HPG-axis interventions and being unable to attribute anything
• Expecting effects on the timescale of testosterone replacement
• Ignoring the pulsatility of the natural system and assuming a flat daily dose mimics it

A tracking template

Per dose: timestamp, amount, route, site. Per day: libido, morning wood, mood, sleep. Per week: weight, energy summary. Per cycle: paired LH, FSH, testosterone, estradiol, prolactin, SHBG drawn at the same time of day. Peptide IA can hold the lab series alongside daily subjective scores so you can see whether the numbers and the felt experience agree.

Safety notes

Kisspeptin-10 is not a casual peptide. Use it with a clinician if you are pursuing a reproductive endpoint, and do not assume short-term tolerability translates to long-term safety.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.